| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/12/2000 | EP1017715A2 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 07/12/2000 | EP1017714A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
| 07/12/2000 | EP1017713A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 07/12/2000 | EP1017712A1 Ucp3 genes |
| 07/12/2000 | EP1017711A2 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action |
| 07/12/2000 | EP1017710A1 Inhibitors of the jnk signal transduction pathway and methods of use |
| 07/12/2000 | EP1017707A1 29 human secreted proteins |
| 07/12/2000 | EP1017423A1 Cloning pigs using donor nuclei from differentiated cells |
| 07/12/2000 | EP1017422A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 07/12/2000 | EP1017421A1 Method and compositions for healing tissue defects and inducing hypervascularity in mammalian tissue |
| 07/12/2000 | EP1017418A1 Vaccine composition for preventing or treating c hepatitis |
| 07/12/2000 | EP1017416A1 Treatment of cardiomyopathy |
| 07/12/2000 | EP1017415A1 Product for promoting dural or meningeal tissue growth comprising collagen |
| 07/12/2000 | EP1017414A1 Therapeutic method for management of diabetes mellitus |
| 07/12/2000 | EP1017413A1 LIQUID INTERFERON-$g(b) FORMULATIONS |
| 07/12/2000 | EP1017412A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease |
| 07/12/2000 | EP1017411A1 COMPOSITIONS SUITABLE FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS |
| 07/12/2000 | EP1017410A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds |
| 07/12/2000 | EP1017407A2 Useful properties of human lactoferrin and variants thereof |
| 07/12/2000 | EP1017405A1 Therapeutic hemoglobin composition having isotropically increased size |
| 07/12/2000 | EP1017402A1 Control of acidic gut syndrome |
| 07/12/2000 | EP1017397A1 Photosensitizer conjugates for pathogen targeting |
| 07/12/2000 | EP1017389A1 Prevention of adhesions and excessive scar formation using angiogenesis inhibitors |
| 07/12/2000 | EP1017383A1 Thrombin inhibitors |
| 07/12/2000 | EP1017382A1 Biarylalkanoic acids as cell adhesion inhibitors |
| 07/12/2000 | EP1017373A2 REGULATION OF CELLULAR APOPTOSIS USING MODULATORS OF $g(b)-AR RECEPTORS |
| 07/12/2000 | EP1017370A1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) |
| 07/12/2000 | EP1017367A1 Methods for fabricating polymer-based controlled release preparions |
| 07/12/2000 | EP1017366A1 Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| 07/12/2000 | EP1017364A1 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 07/12/2000 | EP0918545B1 Tumour therapy |
| 07/12/2000 | EP0901405A4 Fibrinogen apparatus, method and container |
| 07/12/2000 | EP0798971B1 Increasing creatine and glycogen concentration in muscle |
| 07/12/2000 | EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 07/12/2000 | EP0680336B1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 07/12/2000 | EP0673390B1 Delta-like gene expressed in neuroendocrine tumors |
| 07/12/2000 | EP0662146B1 Dorsal tissue affecting factor and compositions |
| 07/12/2000 | EP0635027B1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
| 07/12/2000 | EP0610345B1 Combined cellular and immunosuppressive therapies |
| 07/12/2000 | EP0584228B1 A method of producing thermoplastic polymeric material |
| 07/12/2000 | EP0580694B1 Production of phosphopeptides from casein |
| 07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 07/12/2000 | CN1260006A Complex formation between dsDNA and oligomer of heterocycles |
| 07/12/2000 | CN1260000A Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines |
| 07/12/2000 | CN1259999A Human bikunin |
| 07/12/2000 | CN1259998A Modified retinoblastoma tumor suppressor protein |
| 07/12/2000 | CN1259962A Anti-vegf antibodies |
| 07/12/2000 | CN1259961A Humanized antibodies and method for forming same |
| 07/12/2000 | CN1259959A GnRh antagonists being modified in positions 5 and 6 |
| 07/12/2000 | CN1259958A Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 07/12/2000 | CN1259873A Bio-pharmaceutical prepn. contg. live culture of bacillus and method treating viral and bacterial infection as well as immuno-deficiency conditions |
| 07/12/2000 | CN1259523A Immuno active polypeptide for treating psoriasis and its prepn. method |
| 07/12/2000 | CN1259386A Isoniazid synergistic compound aerosol and its prepn. method |
| 07/12/2000 | CN1259385A Arsenic, enzyme compound medicine and prepn. for directly applied on cancer focus and prepn. method thereof |
| 07/11/2000 | US6087489 Antisense oligonucleotide modulation of human thymidylate synthase expression |
| 07/11/2000 | US6087487 Cdna molecule encoding a protein having nap domains and factor xa inhibitory activity; for in vitro diagnostic agents; in vivo therapy |
| 07/11/2000 | US6087486 Dna molecules encoding rip-1 protein which binds to the human immunodeficiency virus viral protein r; viricides and prophylactic agents |
| 07/11/2000 | US6087484 Contacting target rna with mixture; activation without reducing specificity |
| 07/11/2000 | US6087483 DNA coding an inositol 1,4,5,-triphosphate binding protein |
| 07/11/2000 | US6087479 Introducing into patient a medical device of which at least a portion includes a nitric oxide adduct which may be a sodium nitroprusside, a nitrosothiol, a nitrate, a nitrite or a nitrosated amino acid |
| 07/11/2000 | US6087477 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 07/11/2000 | US6087473 Kunitz domain polypeptide and materials and methods for making it |
| 07/11/2000 | US6087441 Oligopeptide or polypeptide |
| 07/11/2000 | US6087383 A viricide have high solubility/dissolution rate and oral bioavailability |
| 07/11/2000 | US6087375 Methods of treating or preventing thromboses |
| 07/11/2000 | US6087370 Methods of treatment using lamellarin-class alkaloids |
| 07/11/2000 | US6087352 Administering to a female horses and pigs, to control the estrous cycle so that the timing of fertility may be selected |
| 07/11/2000 | US6087343 Antisense oligonucleotides targeted to β-1 adrenoceptor and methods of use |
| 07/11/2000 | US6087338 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 07/11/2000 | US6087337 Treating melanomas or metastases of malignant melanomas by topically administering to mammal at the site of melanoma with a cyclic or linear octapeptide somatostatins |
| 07/11/2000 | US6087336 Peptide derivatives useful in treating autoimmune diseases |
| 07/11/2000 | US6087335 Administering a polypeptide isolated from coriolus versicolor as an antitumor agent |
| 07/11/2000 | US6087334 Anti-diabetic peptides |
| 07/11/2000 | US6087333 Disease associated acidic protein |
| 07/11/2000 | US6087332 Streptokinase derivatives with high affinity for activated platelets and methods of their production and use in thrombolytic therapy |
| 07/11/2000 | US6087330 Process to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides therefor |
| 07/11/2000 | US6087329 A genetic engineered cd40-l polypeptide that binds cd40, and comprises an extracellular region, transmembrane region and cytoplasmic region |
| 07/11/2000 | US6087327 Administering to a muscle a dosage of a drug containing a mixture of first and second neurotoxins sufficient to cause localized denervation |
| 07/11/2000 | US6087326 A mixture of an isolated mammamlian netrin and an isolated mammalian netrin receptor selected from the group consisting of ?deleted in colorectal carcinoma? and neogenin |
| 07/11/2000 | US6087325 Peptide-lipid conjugates |
| 07/11/2000 | US6087324 Sustained-release preparation |
| 07/11/2000 | US6087323 Use of neuregulins as modulators of cellular communication |
| 07/11/2000 | US6087186 Synthetic library of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer; for drug screening |
| 07/11/2000 | US6087178 Method for down regulating CD4 expression in a T cell |
| 07/11/2000 | US6087173 Antisense modulation of X-linked inhibitor of apoptosis expression |
| 07/11/2000 | US6087172 For treatment of rheumatoid arthritis by suppression of interleukin-15 production |
| 07/11/2000 | US6087169 HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide |
| 07/11/2000 | US6087167 Promoting neuron survival or neurite outgrowth by contacting neurons with an amount of an eck receptor binding protein of specific amino acid sequence |
| 07/11/2000 | US6087161 Recombinant polynucleotide of promoter and sequence encoding protein with translation stop codon in open reading frame at 3' end resuling in deletion of c-terminal amino acids important for vacuolar targeting; for fungi resistant plants |
| 07/11/2000 | US6087160 Programmed cell death genes and proteins |
| 07/11/2000 | US6087153 Sel-10 and uses thereof |
| 07/11/2000 | US6087150 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 07/11/2000 | US6087144 Mammalian enzymatic protein receptor; for the activation of cell differentiation and propagation; for screening modulators or receptor activity |
| 07/11/2000 | US6087142 Valyl tRNA synthetase from streptococcus pneumoniae |
| 07/11/2000 | US6087129 Recombinant expression of proteins from secretory cell lines |
| 07/11/2000 | US6087127 Nucleotide sequence which codes a viral disease polypeptide; for the development of vaccines for prevention of viral infection |
| 07/11/2000 | US6087126 Bactericidal/permeability-increasing protein (BPI) deletion analogs |
| 07/11/2000 | US6087125 Polynucleotide encoding a novel human nm23-like protein |
| 07/11/2000 | US6087123 Metal-containing ribonucleotide polypeptides |
| 07/11/2000 | US6087122 Polynucleotide sequence which codes a mammalian polypeptide synthetases; for diagnosis, evaluation, prevention, and treatment of physiological defects |